Insider · CIK 0001878867

Alexander Kristen

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001878867

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−15.9K sh	—	—	15,927
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−19.9K sh	—	—	39,773
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+10.6K sh	—	—	58,417
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+15.9K sh	—	—	74,343
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+19.9K sh	—	—	94,230
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance and Accounting	FTax Payment	−17.9K sh	$0.67	−$12K	76,368
2025-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−10.6K sh	—	—	0
2025-02-13	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance and Accounting	AAward	+186K sh	—	—	185,540
2025-02-13	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance and Accounting	AAward	+186K sh	—	—	185,540
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−15.9K sh	—	—	31,853
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−2,700 sh	—	—	0
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−10.6K sh	—	—	10,617
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+2,700 sh	—	—	33,050
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+10.6K sh	—	—	43,666
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+15.9K sh	—	—	59,593
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance and Accounting	FTax Payment	−11.8K sh	$2.62	−$30.9K	47,800
2024-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance and Accounting	AAward	+59.7K sh	—	—	59,660
2024-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance and Accounting	AAward	+59.7K sh	—	—	59,660
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+2,700 sh	—	—	25,063
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−10.6K sh	—	—	21,233
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−2,700 sh	—	—	2,700
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−5,400 sh	—	—	0
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance and Accounting	FTax Payment	−5,330 sh	$2.17	−$11.6K	30,350
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+10.6K sh	—	—	35,680
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+5,400 sh	—	—	22,363
2023-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance and Accounting	AAward	+47.8K sh	—	—	47,780
2023-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance and Accounting	AAward	+71.7K sh	—	—	71,670
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+5,400 sh	—	—	17,600
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+2,700 sh	—	—	20,300
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	+3,200 sh	—	—	12,200
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−2,700 sh	—	—	5,400
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−5,400 sh	—	—	5,400
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	VP, Finance and Accounting	MExercise/Conversion	−3,200 sh	—	—	0
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	VP, Finance and Accounting	FTax Payment	−3,337 sh	$2.85	−$9,510.45	16,963
2022-02-10	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	VP, Finance and Accounting	AAward	+31.9K sh	—	—	31,850
2022-02-10	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	VP, Finance and Accounting	AAward	+47.8K sh	—	—	47,780

Recent filings

Accepted (ET)
Mar 34
Alexander Kristen0001127602-25-007540
SEC(opens sec.gov)
Feb 184
Alexander Kristen0001127602-25-005225
SEC(opens sec.gov)
Feb 294
Alexander Kristen0001127602-24-007629
SEC(opens sec.gov)
Feb 124
Alexander Kristen0001127602-24-004472
SEC(opens sec.gov)
Mar 14
Alexander Kristen0001127602-23-007933
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.VP, Finance and AccountingLXRX

Address

2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR

THE WOODLANDS, TX, 77381